This is a working overview of bremelanotide, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-17. Anything still debated is marked as such rather than presented as settled.
Bremelanotide is a cyclic heptapeptide that binds several melanocortin receptors rather than one. In vitro assays report agonist activity at MC1R, MC3R, MC4R and MC5R, with MC4R generally treated as the subtype most relevant to sexual effects. MC4R is expressed in hypothalamic nuclei involved in appetite, energy balance and motivated behaviour, which provides a plausible route for central action. Selective MC4R agonists studied in animals produce comparable behavioural changes, supporting that interpretation.
How receptor activation translates into a change in desire is not established in detail. Proposed steps include modulation of dopaminergic signalling in reward circuits and downstream effects on autonomic tone. Human data consist mainly of clinical trials measuring self-reported outcomes rather than direct measurements of brain activity or transmitter release. The transient rise in blood pressure sometimes observed after administration is likewise reported consistently but explained only partly by known melanocortin pathways.
Reported pharmacodynamic effects include transient rises in blood pressure and heart rate, flushing, nausea and headache, appearing soon after dosing and resolving within hours. These responses were dose-related in early studies and shaped the label's cardiovascular cautions and blood pressure monitoring advice. Gastrointestinal upset is the most frequent reason cited for discontinuation in trials. Whether the vascular signal attenuates with repeated use is not settled. Central effects on desire are described as emerging over weeks rather than immediately, which points to a cumulative rather than acute process.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
After subcutaneous dosing, peak plasma concentrations appear within roughly one hour, and elimination is fast, with a half-life on the order of a few hours. Degradation is mainly proteolytic, and at least one circulating fragment retains receptor activity, so parent-drug levels alone do not describe total exposure. Clearance does not depend heavily on hepatic cytochrome enzymes, which lowers the likelihood of common metabolic interaction routes. Data in renal or hepatic impairment are limited. Repeated dosing does not appear to produce marked accumulation given the short half-life.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R agonist | Subtype most often linked to behavioural effects |
| Other reported targets | MC1R, MC3R, MC5R | Activity is not selective for a single subtype |
| Endogenous ligand class | Melanocortin peptides | Alpha-MSH and ACTH act on the same family |
| Peptide architecture | Cyclic heptapeptide | Lactam bridge between the aspartate and lysine residues |
| Central action | Inferred from animal models | Not directly measured in the human brain |
Activation of MC4R in the hypothalamus is thought to influence dopaminergic signaling, which in turn affects arousal and desire. This mechanism differs from that of phosphodiesterase type 5 inhibitors, which act primarily on vascular smooth muscle in the genital region. Because the pathway is central rather than peripheral, effects are not strictly dependent on local blood flow. The precise downstream cascade linking receptor binding to behavioral outcomes remains an area of ongoing investigation.
Clinical development of bremelanotide proceeded through several reformulation attempts. An early intranasal version was discontinued, and a subcutaneous auto-injector formulation later received approval for hypoactive sexual desire disorder in premenopausal women. Approval decisions have varied by country and over time, and the product has not been universally adopted. Blood pressure elevation is a documented effect, which is why some jurisdictions require monitoring after administration. The clinical evidence base continues to evolve as additional studies are published.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
=== MSNovelist: De novo structure prediction === MSNovelist is a computational method for the de novo generation of small molecule structures. It addresses a key limitation of database search tools, which can only identify compounds already present in reference structure databases. This makes it particularly useful for analyzing poorly represented analyte classes and novel compounds. It is not intended to replace database searches altogether, but generates structures which can serve as a great starting point for elucidation of specific unknowns. MSNovelist functions by generating novel molecular structures based on the molecular formula (identified by SIRIUS) and the molecular fingerprint (predicted by CSI:FingerID) of the unknown compound. An encoder–decoder recurrent neural network (RNN) model is trained to translate the input fingerprint into a structure, represented as a SMILES sequence, under the constraints of the predicted molecular formula. MSNovelist generates multiple candidate structures from the predicted molecular fingerprint. Once the candidate structures are generated, they are ranked using CSI:FingerID.
== Interactions == Being metabolized only to a small extent, the substance has a low potential for interactions. In studies, inhibitors of the liver enzymes CYP3A4, CYP2C19, and CYP2C9, as well as the CYP3A4 inducer rifampicin, had no relevant influence on baricitinib concentrations in the bloodstream. While baricitinib blocks a number of transporter proteins in vitro, clinically relevant interactions via this mechanism are considered very unlikely, except perhaps for the cation transporter SLC22A1 (OCT1). An additive effect with other immunosuppressants cannot be excluded.
Ahizechukwu Chigoziem Eke is a Nigerian-American physician-scientist, obstetrician-gynecologist, and specialist in maternal-fetal medicine. He is a 2024 recipient of the NIH Director's Pioneer Award, and has led influential pharmacologic research in pregnant women. He is an Associate Professor in the Division of maternal-fetal medicine at the Johns Hopkins University School of Medicine, where he directs the integrated maternal-fetal medicine research program. Eke is internationally recognized for his research in pharmacology in pregnancy and lactation, with contributions spanning clinical pharmacology, infectious diseases in pregnancy, translational science, and implementation research.
The spot capacity (analogous to peak capacity in HPLC) can be increased by developing the plate with two different solvents, using two-dimensional chromatography. The procedure begins with development of a sample loaded plate with first solvent. After removing it, the plate is rotated 90° and developed with a second solvent.
The modification of the pKa's is a pure part of the electrostatic mechanism. The catalytic effect of the above example is mainly associated with the reduction of the pKa of the oxyanion and the increase in the pKa of the histidine, while the proton transfer from the serine to the histidine is not catalyzed significantly since it is not the rate determining barrier. Note that in the example shown, the histidine conjugate acid acts as a general acid catalyst for the subsequent loss of the amine from a tetrahedral intermediate. Evidence supporting this proposed mechanism (Figure 4 in Ref. 13) has, however, been controverted.
Sources: en.wikipedia.org
== History of paper chromatography == The discovery of paper chromatography in 1943 by Martin and Synge provided, for the first time, the means of surveying constituents of plants and for their separation and identification. Erwin Chargaff credits in Weintraub's history of the man the 1944 article by Consden, Gordon and Martin. There was an explosion of activity in this field after 1945.
=== Taxonomy and nomenclature === Fungaria are central to systematics research based on the comparative study of preserved specimens. Each newly described species must be documented by a designated specimen deposited in a recognized public collection. Type specimens are the only absolute link between a fungal species name and its taxonomic application, and fungaria provide an unmatched source of genetic data from taxonomically authoritative material. Because a type specimen anchors a name rather than representing the full range of a species, accurate identification and revisionary work also depend on examining broader sets of authenticated specimens spanning geography, hosts, and time. In phylogenetic-taxonomic work, sequences from type material are the preferred reference points; when original types are too old to yield reliable DNA, recently collected epitypes may be designated to provide sequence-backed name anchors. Taxonomy in the post-genomic era increasingly relies on sequencing type specimens to anchor species hypotheses, while examination of a broad array of preserved specimens from different growth stages and geographic areas helps define the range of variation within a species. Sampling multiple specimens of the same species can also reveal misidentified material, cryptic species, and species complexes when molecular clusters do not match morphological determinations.
As ETD is increasingly popular for protein and peptide structure analysis, implementation on easily available ion-trap mass spectrometers coupled with high resolution mass analyzers continues to evolve.
== Nanocellulose based water purification system == Nanocellulose based renewable material has a combination of high surface area with high material strength. It is chemically inert and possesses versatile hydrophilic surface chemistry. These properties make them a most promising nanomaterial for usage as a membrane and filter in water purification systems to remove bacterial and chemical contaminants from polluted water. It is noted that nanocellulose material has high potential in water purification technology. Different types of nanocellulose materials available for water purification system includes Cellulose nanocrystals (CNC) and Cellulose nanofibrils (CNF). These are the rod-like nanomaterials whose size ranges from 100 to 2000 nm with the diameter of 2 to 20 nm. Those length and diameter are mostly based on origin and preparation route for the synthesis of nanocellulose. Those nanocellulose materials are used to remove organic pollutants in water such as dyes, oils and pesticides traces present in water. Currently, fully biobased membrane using nanocellulose are fabricated which is used to remove metal ions such as Cu2+, Fe2+ etc, sulfates, fluorides and other organic compounds. This bio-based nanocellulose filter has more advantage to conventional filters. Nanocellulose is prepared by various methods such as sulphuric acid hydrolysis and mechanical grinding method. Water purification system is mainly based on the principle of absorption.
Sources: en.wikipedia.org
The town was founded in 1515 by Mani Ram, a Zamindar under the Lodhi Dynasty. By the 18th century, his descendent Gangaram Singh governed Manimajra and 84 surrounding villages as a Mughal vassal. Following the decline of Mughal authority, Gangaram's son, Gharib Dass, established the independent Manimajra State. Despite early conflicts with the Raja of Nahan, Gharib Dass expanded his territory, seizing Pinjore and establishing the Manimajra Fort as his capital. Upon his death in 1783, his son Raja Gopal Singh took over, eventually receiving the title of Raja from the British in 1814 for his service in the Gurkha campaign. Gopal Singh is notably responsible for building the Mansa Devi Temple (1811–1815). The dynasty continued through Raja Goverdhan Singh and Raja Gurbaksh Singh, ending with Raja Bhagwan Singh, who died without a male heir in 1866. Consequently, the British annexed the state, and the fort later passed to the Raja of Faridkot through marriage.
There are over 800 extant species of cephalopod, although new species continue to be described. An estimated 11,000 extinct taxa have been described, although the soft-bodied nature of cephalopods means they are not easily fossilised. Cephalopods are found in all the oceans of Earth. None of them can tolerate fresh water, but the brief squid, Lolliguncula brevis, found in the Chesapeake Bay, is a notable partial exception in that it tolerates brackish water. Cephalopods are thought to be unable to live in fresh water due to multiple biochemical constraints, and in their >400 million year existence have never ventured into fully freshwater habitats. Cephalopods occupy most of the depth of the ocean, from the abyssal plains to the sea surface, and have also been found in the hadal zone. Their diversity is greatest near the equator (~40 species retrieved in nets at 11°N by a diversity study) and decreases towards the poles (~5 species captured at 60°N).
=== Preterm Labor === The BSCI compound called 'BN83470' in pregnant mice averted infection-induced preterm birth (PTB) by blocking various inflammatory pathways in the uterus and preventing the infiltration of immune cells into the uterine myometrium. In a nonhuman primate model of Group B Streptococcus (GBS)-induced preterm labour, another BSCI compound called 'FX125L' was able to inhibit preterm labour and suppress the cytokine response. No antibiotics were administered during these experiments, allowing the GBS infection to progress and invade the amniotic cavity and the fetus. Despite the invasive GBS infection, prophylactic BSCI treatment significantly reduced the levels of cytokines in the amniotic fluid, fetal plasma, lung, and brain, indicating its ability to suppress the inflammatory response. Current animal studies have not shown any significant fetal toxicity associated with BSCI compounds. However, further research, particularly through human pre-clinical trials, is now underway to understand the impact of BSCIs on the fetal immune response and development.
Sources: en.wikipedia.org
Bremelanotide binds several melanocortin receptors, and MC4R is the subtype most often cited as responsible for its behavioural effects. Activity at MC1R, MC3R and MC5R is also reported. Selectivity is therefore described as limited rather than precise.
It is not classified as a vasodilator, and its proposed site of action is the central nervous system rather than peripheral vessels. Some trial participants show small transient blood pressure changes. Whether those changes arise centrally or through another route remains an open question.
Most evidence comes from animal models and from indirect human outcomes such as self-reported desire. Direct measurements of receptor occupancy or signalling in the human brain are not available. Published reviews therefore present a plausible pathway rather than a confirmed sequence of events.
MC4R is regarded as the primary mediator on the basis of binding and functional assays. Other subtypes are also engaged, which helps explain flushing and related side effects. The step from receptor activation to reported desire change remains partly inferential.